These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
24. [Present aspects of bone marrow lesions due to drugs (author's transl)]. Hausmann K; Skrandies G; Sachtleben P MMW Munch Med Wochenschr; 1974 Sep; 116(38):1621-6. PubMed ID: 4215965 [No Abstract] [Full Text] [Related]
25. Acquired hemoglobin H disease in a patient with aplastic anemia evolving into acute myeloid leukemia. Figueiredo MS; Vicari P; Kimura EY; Antunes SV; Yamamoto M Sao Paulo Med J; 2004 Nov; 122(6):273-5. PubMed ID: 15692723 [TBL] [Abstract][Full Text] [Related]
26. Consensus Conference on the Treatment of Aplastic Anemia. Kojima S; Nakao S; Tomonaga M; Hows J; Marsh J; Gerard S; Bacigalupo A; Mizoguchi H Int J Hematol; 2000 Jul; 72(1):118-23. PubMed ID: 10979223 [TBL] [Abstract][Full Text] [Related]
27. [Transformation into acute leukemia of a case of involutive myelopathy due to benzene poisoning]. Robustelli della Cuna G; Favino A; Biscaldi GP; Pollini G Haematologica; 1972; 57(1):65-89. PubMed ID: 4625169 [No Abstract] [Full Text] [Related]
29. Aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome-acute leukemia in the same patient. The first record of such occurrence. Wasi P; Kruetrachue M; Na-Nakorn S J Med Assoc Thai; 1970 Sep; 53(9):656-63. PubMed ID: 5505666 [No Abstract] [Full Text] [Related]
30. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia]. Olmer J; Muratore R; Gabriel B; Canu AM Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481 [No Abstract] [Full Text] [Related]
31. [Risk of leukemia in aplastic anemias]. Ihle R; Stobbe H; Elstner E; Schulze E Z Gesamte Inn Med; 1983 Feb; 38(3):75-7. PubMed ID: 6573823 [TBL] [Abstract][Full Text] [Related]
32. In vitro evidence of drug action in aplastic anemia. Vincent PC Blut; 1984 Jul; 49(1):3-12. PubMed ID: 6378281 [No Abstract] [Full Text] [Related]
36. [Myeloid aplasias with myeloid leukemia: old truths versus new ideas]. Sánchez-Fayos J; Outeiriño J; Fernández-Rañada JM; Paniagua G Sangre (Barc); 1973; 18(3):266-70. PubMed ID: 4518943 [No Abstract] [Full Text] [Related]
37. [Globular aplastic myelosis with diffuse osteosclerosis due to chronic xylene poisoning]. GIAMMARINARO G Osp Maggiore; 1956 May; 44(5):281-5. PubMed ID: 13349254 [No Abstract] [Full Text] [Related]
38. [Clinical course of severe acquired aplastic anemia to myelodysplastic syndrome and acute leukosis]. González-Barca E; Domingo A; Fernández de Sevilla A; Grañena A Med Clin (Barc); 1995 Jul; 105(6):224-6. PubMed ID: 7658741 [TBL] [Abstract][Full Text] [Related]
39. Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate. LeMarbre G; Schinstock C; Hoyer R; Krook J; Tefferi A Leuk Res; 2007 Mar; 31(3):414-5. PubMed ID: 17010430 [No Abstract] [Full Text] [Related]
40. Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia. Lazarevic V; Wahlin A Bone Marrow Transplant; 2007 Jan; 39(1):53-4. PubMed ID: 17115065 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]